The crucial role of NRF2 in erythropoiesis and anemia: Mechanisms and therapeutic opportunities
Authors:
- 5 March 2024
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 754, 109948
Abstract
No abstract availableKeywords
Funding Information
- Yangzhou University (AHYZUCXTD202102)
- Science and Technology Major Project of Guangxi (21-220-222, G202003023, GuikeAD22035121, GuikeZy1949016)
- National Natural Science Foundation of China (81870096)
This publication has 92 references indexed in Scilit:
- Activation of NRF2/FPN1 pathway attenuates myocardial ischemia–reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosisCell Stress and Chaperones, 2022
- Cancer cells escape autophagy inhibition via NRF2-induced macropinocytosisCancer Cell, 2021
- Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron ChelationDrugs, 2020
- Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in β-thalassemiaInternational Journal of Hematology, 2020
- Oxidative Stress in β-ThalassemiaMolecular Diagnosis & Therapy, 2018
- Nrf2, a Regulator of the Proteasome, Controls Self-Renewal and Pluripotency in Human Embryonic Stem CellsStem Cells, 2014
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic ReprogrammingCancer Cell, 2012
- Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patientsPediatric Blood & Cancer, 2007
- ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPα and STAT-3Biochemical and Biophysical Research Communications, 2007
- An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response ElementsBiochemical and Biophysical Research Communications, 1997